THYROCARE.NS Live signals | Maximize Profits with Getagraph.com

Live Chart Being Loaded With Signals

Commentary (9 May 2024 @ 06:00):

Stats
Today's Volume	61 752.00
Average Volume	107 938
Market Cap	32.96B
EPS	INR0 ( 2024-02-01 )
Next earnings date	( INR0 ) 2024-05-14
Last Dividend	INR18.00 ( 2023-04-20 )
Next Dividend	INR0 ( N/A )
P/E	50.94
ATR14	INR1.223 (0.19%)

Volume Correlation

Long: -0.07 (neutral)

Short: 0.94 (very strong)

Signal:(72.284) Expect same movement, but be aware

Thyrocare Technologies Correlation

10 Most Positive Correlations

10 Most Negative Correlations

Did You Know?

Correlation is a statistical measure that describes the relationship between two variables. It ranges from -1 to 1, where -1 indicates a perfect negative correlation (as one variable increases, the other decreases), 1 indicates a perfect positive correlation (as one variable increases, the other increases), and 0 indicates no correlation (there is no relationship between the variables).

Correlation can be used to analyze the relationship between any two variables, not just stocks. It's commonly used in fields such as finance, economics, psychology, and more.

Thyrocare Technologies Correlation - Currency/Commodity

-0.39
( neutral )

-0.63
( weak negative )

-0.14
( neutral )

-0.54
( weak negative )

0.02
( neutral )

0.63
( weak )

Thyrocare Technologies Financials

Annual	2022
Revenue:	INR5.27B
Gross Profit:	INR3.63B (69.01 %)
EPS:	INR12.16

FY	2022
Revenue:	INR5.27B
Gross Profit:	INR3.63B (69.01 %)
EPS:	INR12.16

FY	2022
Revenue:	INR5.89B
Gross Profit:	INR4.19B (71.18 %)
EPS:	INR33.30

FY	2021
Revenue:	INR4.95B
Gross Profit:	INR3.31B (66.86 %)
EPS:	INR21.41

Financial Reports:

No articles found.

Thyrocare Technologies Dividends

(Q3/22)	(Q4/22)	(Q1/23)	(Q2/23)	(Q3/23)	(Q4/23)	(Q1/24)	(Q2/24)	(Q3/24)	(Q4/24)
INR0 (N/A)	INR0 (N/A)	INR0 (N/A)	INR18.00 (N/A)	INR0 (N/A)	INR0 (N/A)	INR0 (N/A)	INR0 (N/A)	INR0 (N/A)	INR0 (N/A)

Thyrocare Technologies Dividend Information - Dividend Junior

Dividend Sustainability Score: 2.68 - low (50.00%) | Divividend Growth Potential Score: 5.11 - Potential for dividend initiation, but uncertain (2.18%)

Very Unsafe

High risk of being cut

Unsafe

Heightened risk of being cut

Borderline

Moderate risk of being cut

Safe

Unlikely to be cut

Very Safe

Very unlikely to be cut

Information

First Dividend	INR2.50	2016-09-01
Last Dividend	INR18.00	2023-04-20
Next Dividend	INR0	N/A
Payout Date	0000-00-00
Next Payout Date	N/A
# dividends	11	--
Total Paid Out	INR105.50	--
Avg. Dividend % Per Year	1.39%	--
Score	2.34	--
Div. Sustainability Score	2.68
Div.Growth Potential Score	5.11
Div. Directional Score	3.90	--

Next Divdend (Est)
(2024-06-24)

INR19.97 Estimate 3.36 %

Dividend Stability

0.27 Very Poor

Dividend Score

2.34

Pay Frequency

Annually

Yearly Payout

Year	Amount	Yield
2016	INR0	0.00%
2017	INR0	0.00%
2018	INR10.00	1.55%
2019	INR25.00	4.64%
2020	INR10.00	1.85%
2021	INR15.00	1.60%
2022	INR15.00	1.35%
2023	INR18.00	2.94%
2024	INR0	0.00%

Dividend Commentary

The company's low Dividend Sustainability Score (DSS) highlights potential challenges in upholding its current dividend levels. However, its Dividend Growth Potential Score (DGPS) is only moderate, indicating limited growth potential. In conclusion, a more vigilant stance is recommended given the company's tentative dividend landscape.

Top 10 dividend Companies for NSE

Symbol	Title	Last dividend	Frequency	Years Dividend	Yearly Dividend
QUICKHEAL.NS	Dividend Junior	2023-07-28	Annually	9	1.26%
KENNAMET.NS	Dividend Knight	2023-05-25	Annually	4	0.76%
ELECTCAST.NS	Dividend Junior	2023-09-04	Annually	23	1.51%
AHLUCONT.NS	Dividend Junior	2023-09-22	Sporadic	15	0.04%
SUNTV.NS	Dividend Knight	2023-08-22	Quarterly	19	1.94%
NAVA.NS	Dividend Knight	2023-07-24	Annually	23	2.35%
HONAUT.NS	Dividend Junior	2023-08-03	Annually	21	0.15%
CARBORUNIV.NS	Dividend Knight	2023-07-25	Semi-Annually	23	0.33%
ROSSELLIND.NS	No Dividend Player	2023-07-20	Sporadic	12	0.12%
LAURUSLABS.NS	Dividend Knight	2023-05-10	Semi-Annually	8	0.35%

Dividend Sustainability Score (DSS)

Ratio	Actual Value	Weight	Normalized Value	Score	Range
netProfitMarginTTM	0.118	1.500	7.63	10.00	[0 - 0.5]
returnOnAssetsTTM	0	1.200	0	0	[0 - 0.3]
returnOnEquityTTM	0.128	1.500	9.69	10.00	[0.1 - 1]
payoutRatioTTM	0	-1.000	0	0	[0 - 1]
currentRatioTTM	0	0.800	-5.00	-4.00	[1 - 3]
quickRatioTTM	0	0.800	-4.71	-3.76	[0.8 - 2.5]
cashRatioTTM	0	1.500	-1.111	-1.667	[0.2 - 2]
debtRatioTTM	0	-1.500	0	0	[0 - 0.6]
interestCoverageTTM	24.85	1.000	1.909	1.909	[3 - 30]
operatingCashFlowPerShareTTM	16.82	2.00	4.39	8.79	[0 - 30]
freeCashFlowPerShareTTM	16.82	2.00	1.590	3.18	[0 - 20]
debtEquityRatioTTM	0	-1.500	0	0	[0 - 2.5]
grossProfitMarginTTM	0.708	1.000	1.541	1.541	[0.2 - 0.8]
operatingProfitMarginTTM	0.168	1.000	8.63	8.63	[0.1 - 0.6]
cashFlowToDebtRatioTTM	0	1.000	-1.111	-1.111	[0.2 - 2]
assetTurnoverTTM	0	0.800	-3.33	-2.67	[0.5 - 2]
Total Score				2.68

Dividend Growth Score (DGS)

Ratio	Actual Value	Weight	Normalized Value	Score	Range
peRatioTTM	50.08	1.000	5.04	0	[1 - 100]
returnOnEquityTTM	0.128	2.50	9.80	10.00	[0.1 - 1.5]
freeCashFlowPerShareTTM	16.82	2.00	4.39	3.18	[0 - 30]
dividendYielPercentageTTM	0	1.500	0	0	[0 - 0.4]
operatingCashFlowPerShareTTM	16.82	2.00	4.39	8.79	[0 - 30]
payoutRatioTTM	0	1.500	0	0	[0 - 1]
pegRatioTTM	0.902	1.500	7.32	0	[0.5 - 2]
operatingCashFlowSalesRatioTTM	0.161	1.000	8.48	0	[0.1 - 0.5]
Total Score				5.11

Thyrocare Technologies

Thyrocare Technologies Limited provides diagnostic testing services to patients, laboratories, and hospitals in India. It operates in three segments: Diagnostic Testing Services, Imaging Services, and Others. The company conducts various medical diagnostic tests and profiles of tests that focuses on early detection and management of disorders and diseases, including thyroid, growth, metabolism, auto-immunity, diabetes, anaemia, cardiovascular, infertility, COVID, and various infectious diseases. Its profiles of tests include 34 profiles of tests administered under its Aarogyam brand, which offers patients a suite of wellness and preventive health care tests. The company also sells glucometer and glucostrips under the brand name Sugarscan; consumables; and radiopharmaceutical. Thyrocare Technologies Limited was founded in 1996 and is based in Navi Mumbai, India. Thyrocare Technologies Limited is a subsidiary of Docon Technologies Private Limited.

Realtime updates for Thyrocare Technologies [THYROCARE.NS]

Upcoming Earnings Alert

Thyrocare Technologies Dividend Information - Dividend Junior

Dividend Commentary

Top 10 dividend Companies for NSE

Dividend Sustainability Score (DSS)

Dividend Growth Score (DGS)